Генерализованное тревожное расстройство: как помочь пациенту с нарушениями сна

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington: American Psychiatric Association; 2001. American Psychiatric Association. DSM-IV-TR.
2. http://www.who.int/classifications/apps/icd/icd10online/
3. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593–602.
4. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–27.
5. Greenberg PE, Sisitky T, Kessler RC et al. The economic burden of anxiety disorders n the 1990s. J Clin Psychiatry 1999; 60: 427–35.
6. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 355–64.
7. Olfson M, Fireman B, Weissman MM et al. Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry 1997; 154: 1734–40.
8. Brawman-Mintzer O, Lydiard RB. Generalized anxiety disorder: Issues in epidemiology. J Clin Psychiatry 1996; 57 (Suppl. 7): 3–8.
9. Jindal R, Buysse D, Thase M. Maintenance treatment of insomnia: what can we learn from the depression literature? Am J Psychiatry 2004; 161: 19–24.
10. Ringdahl E, Pereira S, Delzell J. Treatment of primary insomnia. J Am Board Fam Pract 2004; 17: 212–9.
11. Ohayon M, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatric Res 2003; 37: 9–15.
12. Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med 2007: 7–10.
13. Monti J, Monti D. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med Rev 2000; 4: 263–76.
14. Lamberg L. Don't sleep on decision to start insomnia treatment. Psychiatric News 2006; 4: 22.
15. Ohayon M. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997; 31: 333–46.
16. Ford DE, Kamerow DB. Epidemiologic Study of sleep disturbances and psychiatric disorders an opportunity for prevention? JAMA 1989; 262: 1479–84.
17. Culpepper L. Generalized anxiety disorder in primary care: emerging issues in management and treatment. J Clin Psychiatry 2002; 63: 35–42.
18. Belanger L, Morin C, Langlois F et al. Insomnia and generalized anxiety disorder: effects of cognitive behavior therapy for GAD on insomnia symptoms. J Anxiety Disord 2004; 18: 561–71.
19. Bourdet C, Goldenberg F. Insomnia in anxiety: sleep EEG changes. J Psychosom Res 1994; 38: 93–104.
20. Ohayon M, Lemoine P. A connection between insomnia and psychiatric disorders in the French general population. Encephale 2002; 28: 420–8.
21. Taylor D, Lichstein K, Durrence H et al. Epidemiology of insomnia, depression, and anxiety. Sleep 2005; 28: 1362–3.
22. Papadimitrious G, Linkowski P. Sleep disturbance in anxiety disorders. Int Rev Psychiatry 2005; 17: 229–36.
23. Котова О.В. Тревожные расстройства и нарушения сна. Cons. Med. Неврология. Ревматология. (Прил.). 2012; 1: 29–33.
24. Brenes GA, Miller ME et al. Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry 2009; 17 (6): 465–72.
25. Saletu-Zyhlarz G, Saletu B, Anderer P. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology 1997; 36: 117–29.
26. Nutt D. Neurobiological mechanisms in Generalized Anxiety Disorder. J Clin Psychiatry 2001; 62: 22–7.
27. Morin C, Rodrique S, Ivers H. Role of stress, arousal and coping skills in primary insomnia. Psychosom Med 2003; 65: 259–67.
28. Neubauer D. The evolution and development of insomnia pharmacotherapies. J Clin Sleep Med 2007; 11–5.
29. Baldwin DS, Anderson IM, Nutt DJ et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005; 19: 567–96.
30. Berger A, Edelsberg J, Bollu V et al. Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry 2011; 11: 193.
31. Rickels K, DeMartinis N, Barcia-Espana F et al. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy. Am J Psychiatry 2000; 157: 1973–9.
32. Gorman JM. Treating generalized anxiety disorder. J Clin Psychiatry 2003; 64 (Suppl. 2): 24–9.
33. Lader M. Effectiveness of benzodiazepines: Do they work or not? Exp Rev Neurother 2008; 8: 1189–91.
34. Landi F, Onder G, Cesari M et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005; 60: 622–6.
35. Котова О.В. Депрессивное расстройство с нарушениями сна в общемедицинской практике. Рус. мед. журн. 2012; 8: 431–5.
36. Смулевич А.Б., Павлова Л.К., Железнова М.В. Применение препарата Донормил при лечении нарушений сна средней и легкой степени выраженности. РМЖ. 2006; 14 (23): 1714–9.
37. Котова О.В. Влияние стресса на сон человека. Журн. неврол. и психиатр. им. С.С.Корсакова. 2012; 4 (112): 79–82.
38. Полуэктов М.Г. Нарушения сна в молодом возрасте: инсомнии и расстройства дыхания во сне. Леч. врач. 2011; 5: 10.
39. Полуэктов М.Г. Инсомния и расстройства дыхания во сне: возможности коррекции. РМЖ. 2011; 19 (15): 948–54.

О.В.Котова

Лаборатория патологии вегетативной нервной системы НИО неврологии НИЦ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ